ArticleProceedings of the National Academy of Sciences of the United States of America2025

Multiomics integration prioritizes potential drug targets for multiple sclerosis.

Yuan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.